Saudis to build insulin plant

Here's a prime example of how politics affects the drug biz. Two years ago, a Danish newspaper published some cartoons that offended many Muslims and led to a boycott in some Islamic countries. Now, the Islamic Development Bank is putting up $10 million to help finance an insulin-production plant--in hopes of cutting out major insulin supplier Novo Nordisk. Which, of course, is based in Denmark.

The new plant is slated for a site near Jeddah and will be developed in partnership with Brazilian biotech Biomm. The Saudi firm leading the charge hasn't been identified.

- read the article in Dawn 

Related Articles:
Novo Nordisk reports positive data in diabetes trials. Report
Investigators probing Novo payments. Report
Amgen ups lobbying efforts. Report

Suggested Articles

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

Intent-driven audiences are inspired to make health-improving changes after a positive online experience. Find out what they’re driven to do.

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.